Sri Chavadi Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 21-06-2024
- Paid Up Capital ₹ 3.99 M
as on 21-06-2024
- Company Age 28 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.99 Cr
as on 21-06-2024
- Revenue -10.08%
(FY 2021)
- Profit -65.20%
(FY 2021)
- Ebitda -82.77%
(FY 2021)
- Net Worth 4.88%
(FY 2021)
- Total Assets -26.02%
(FY 2021)
About Sri Chavadi Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.99 M.
The company has closed loans amounting to ₹3.99 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dileep Bakireddy, Devireddy Deepna, Devereddy Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110TG1996PTC023074
- Company No.
023074
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationKottur, Andhra Pradesh, Telangana
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sri Chavadi Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dileep Bakireddy  | Managing Director | 12-Apr-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devireddy Deepna | Director | 30-Sep-2014 | Current |
| Devereddy Reddy | Director | 30-Sep-2014 | Current |
| Sailaja Devireddy | Director | 01-Feb-1996 | Current |
Financial Performance of Sri Chavadi Pharma.
Sri Chavadi Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 10.08% decrease. The company also saw a substantial fall in profitability, with a 65.2% decrease in profit. The company's net worth moved up by a moderate rise of 4.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Chavadi Pharma?
In 2021, Sri Chavadi Pharma had a promoter holding of 86.84% and a public holding of 13.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Corey Organics Private LimitedActive 28 years 9 monthsDileep Bakireddy, Devireddy Deepna and 1 more are mutual person
Sai Sreyas Pharmaceutical Private LimitedActive 14 years 7 monthsDileep Bakireddy and Devereddy Reddy are mutual person
- Sjd Developers Private LimitedActive 10 years 4 months
Dileep Bakireddy and Devereddy Reddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Pradesh State Financial Corporation Creation Date: 11 Apr 2014 | ₹6.50 M | Satisfied |
Andhra Pradesh State Financial Corporation Creation Date: 07 Sep 2010 | ₹1.00 Cr | Satisfied |
State Bank Of Hyderabad Creation Date: 06 Aug 2004 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Sri Chavadi Pharma?
Sri Chavadi Pharma has a workforce of 27 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Chavadi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Chavadi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
